GLUT1 is overexpressed in various solid and hematological malignancies, such as colorectal carcinomas, gastrointestinal stromal tumors, and lung cancers (Zhang et al., 2019), but the correlation with the grade and stage of the tumor and the clinical outcome has not been defined yet (Schuurbiers et al., 2014). The gene discussed is SLC2A1; the disease is lung carcinoma.